HAMDEN, Conn., May 9, 2013 (GLOBE NEWSWIRE) -- TransAct Technologies Incorporated (Nasdaq:TACT), a global leader in market-specific solutions, including printers, terminals, software and other products for transaction-based and other industries, today announced financial results for the three months ended March 31, 2013. Summary results for the periods are as follows:
| Three months ended March 31, | |||
|
(in $000s, except EPS) |
2013 |
2012 |
% Change |
| Net Sales | $15,057 | $17,559 | -14.2% |
| As reported (GAAP): | |||
| Gross profit | 6,433 | 6,778 | -5.1% |
| Gross margin | 42.7% | 38.6% | 410bpts |
| Operating income | 1,402 | 1,910 | -26.6% |
| Net income | 1,160 | 1,208 | -4.0% |
| Diluted earnings per share | $0.13 | $0.13 | 0.0% |
| Adjusted (non-GAAP): | |||
| Gross profit | 6,433 | 6,778 | -5.1% |
| Operating income | 1,601 | 1,964 | -18.5% |
| Net income | 1,290 | 1,243 | 3.8% |
| Diluted earnings per share | $0.15 | $0.13 | 15.4% |
"The first quarter of 2013 was a solid quarter for our newly launched products, as their success helped us achieve gross margin of nearly 43% for the quarter, a significant improvement from the prior-year period," said Bart C. Shuldman, Chairman and Chief Executive Officer of TransAct Technologies. "Our transition toward value-added and higher margin products, including our new color Printrex printers for the oil and gas exploration market, new Ithaca® 9700 food safety terminal and EPICENTRAL® Print System, is beginning to positively affect our financial results. In addition, we recently increased our quarterly dividend by 16.7% and continued to repurchase stock in the quarter, highlighting our strong cash flow generation and our goal of returning value to shareholders. We will continue to focus our efforts on our newly launched products as well as our EPICENTRAL® Print System software as demonstrated with our latest win with the Hippodrome Casino in London."
Mr. Shuldman continued, "For the first quarter of 2013, our worldwide casino and gaming sales declined 28% from the prior-year period as an increase in our domestic casino and gaming sales aided by our first quarter of significant revenue contribution from EPICENTRAL® could not overcome weakness in international sales, especially in Europe. Printrex printer sales for the first quarter of 2013 were $1.3 million, up 7% as we added revenue from our two new color oil and gas printers. While food safety, banking and POS product sales decreased 15% compared to the prior-year period, we were pleased with the increased sales of printers to McDonald's as well as the first full quarter of sales contribution from our new Ithaca® 9700 food safety terminal. TransAct Services Group revenue increased 3% compared to the prior-year period due primarily to higher sales of spare parts, higher service sales and the first full quarter of revenue contribution from consumables for our new Printrex color printers. And lastly, lottery sales to GTECH were $1.4 million, up 33% from the prior-year period due to the timing of orders."
2013 Outlook
TransAct expects sales to ramp up during the remainder of 2013, especially in the second half of the year, as increased sales from the new food safety, Printrex color oil and gas products, as well as EPICENTRAL® software sales continue to build. In addition, TransAct expects its gross margin to continue to benefit from a more favorable sales mix of these new products.
First Quarter 2013 Results
Revenue for the first quarter of 2013 was $15.1 million, a decrease of 14% compared to $17.6 million in the prior-year period. Gross margin for the first quarter of 2013 increased to 42.7% from 38.6% in the prior-year quarter due primarily from sales of the Company's newly launched EPICENTRAL®, Printrex and food safety products. Operating expenses were $5.0 million, an increase of $0.2 million from the prior-year period. Excluding non-GAAP adjustments, operating expenses were $4.8 million, consistent with the prior-year period. The Company recorded GAAP net income of $1.2 million, or $0.13 per diluted share, in the first quarter of 2013, consistent with the prior-year period. Excluding non-GAAP adjustments, the Company recorded adjusted net income in the first quarter of 2013 of $1.3 million, or $0.15 per diluted share. For a reconciliation of GAAP to non-GAAP measures, please review the disclosures and tables included within this release.
Commenting on the financial results, Steven A. DeMartino, President and Chief Financial Officer of TransAct Technologies said, "We experienced a significant 410 basis point increase in our gross margin during the first quarter of 2013 as our newer, higher margin EPICENTRAL®, Printrex and food safety products began to generate material sales. Our transition to the new value-added products is now in place and we will continue to focus our efforts during 2013 on growing sales of these new products. Finally, our balance sheet remains in great condition with a current ratio of nearly 5.0, $8.4 million in cash and cash equivalents and no debt outstanding as of March 31, 2013."
Liquidity and Capital Resources
As of March 31, 2013, the Company had approximately $8.4 million in cash and cash equivalents, and no debt obligations outstanding under its $20 million revolving credit facility. During the first quarter of 2013, TransAct repurchased 88,900 shares for approximately $0.7 million (average price of $7.78 per share). TransAct's $15 million repurchase program allows the Company to repurchase up to $5.5 million in additional shares through May 2013.
Financial Presentation
The Company has provided adjusted non-GAAP financial measures because the Company believes that these amounts are helpful to investors and others to more accurately assess the ongoing nature of TransAct's core operations. The adjusted non-GAAP measures exclude the effect in the applicable periods presented of non-GAAP adjustments contained in the tables included with this release. These items have been excluded from adjusted non-GAAP financial measures as management does not believe that they are representative of underlying trends in the Company's performance. Their exclusion provides investors and others with additional information to more readily assess the Company's operating results. The Company uses the non-GAAP financial measures internally to focus management on the results of the Company's core business. The presentation of this additional non-GAAP information is not considered superior to or a substitute for the financial information prepared in accordance with GAAP.
Investor Conference Call / Webcast Details
TransAct will review detailed first quarter 2013 results during a conference call today at 5:00 PM EDT. The conference call-in number is 888-438-5524. A replay of the call will be available from 8:00 PM EDT on Thursday, May 9 through midnight EDT on Thursday, May 16 by telephone at 877-870-5176; passcode 2151363. Investors can also access the conference call via a live webcast on the Company's Web site at http://www.transact-tech.com. A replay of the call will be archived on that Web site for one week.
About TransAct Technologies Incorporated
TransAct Technologies Incorporated (Nasdaq:TACT) is a leader in developing and manufacturing market-specific solutions, including printers, terminals, software and other products for transaction-based and other industries. These industries include casino, gaming, lottery, banking, point-of-sale, food safety, hospitality, oil and gas, and medical and mobile. Each individual market has distinct, critical requirements for printing and the transaction is not complete until the receipt and/or ticket is produced. TransAct printers and products are designed from the ground up based on market specific requirements and are sold under the Ithaca®, Epic, EPICENTRAL® and Printrex® product brands. TransAct distributes its printers through OEMs, value-added resellers, selected distributors, and direct to end-users. TransAct has over 2.4 million printers installed around the world. TransAct is also committed to providing world-class printer service, spare parts, accessories and printing supplies to its growing worldwide installed base of printers. Through its TransAct Services Group, TransAct provides a complete range of supplies and consumables items used in the printing and scanning activities of customers in the hospitality, banking, retail, gaming, government and oil and gas exploration markets. Through its webstore, http://www.transactsupplies.com, and a direct selling team, TransAct addresses the on-line demand for these products. TransAct is headquartered in Hamden, CT. For more information, please visit http://www.transact-tech.com or call 203.859.6800.
Forward-Looking Statements
Certain statements in this press release include forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology, such as "may", "will", "expect", "intend", "estimate", "anticipate", "believe" or "continue" or the negative thereof or other similar words. All forward-looking statements involve risks and uncertainties, including, but are not limited to, customer acceptance and market share gains, both domestically and internationally, in the face of substantial competition from competitors that have broader lines of products and greater financial resources; introduction of new products into the marketplace by competitors; successful product development; dependence on significant customers; dependence on significant vendors; dependence on contract manufacturers for the assembly of a large portion of our products in China; the ability to protect intellectual property; the ability to recruit and retain quality employees as the Company grows; dependence on third parties for sales outside the United States, including Australia, New Zealand, Europe, Latin America and Asia; economic and political conditions in the United States, Australia, New Zealand, Europe, Latin America and Asia; marketplace acceptance of new products; risks associated with foreign operations; availability of third-party components at reasonable prices; price wars or other significant pricing pressures affecting the Company's products in the United States or abroad; risks associated with potential future acquisitions; the outcome of the lawsuit between TransAct and Avery Dennison Corporation; and other risk factors detailed from time to time in TransAct's reports filed with the Securities and Exchange Commission. Actual results may differ materially from those discussed in, or implied by, the forward-looking statements. The forward-looking statements speak only as of the date of this release and the Company assumes no duty to update them to reflect new, changing or unanticipated events or circumstances.
| TRANSACT TECHNOLOGIES INCORPORATED | ||
| CONDENSED CONSOLIDATED STATEMENTS OF INCOME | ||
| (Unaudited) | ||
| (In thousands, except per share amounts) |
Three months ended March 31, |
|
| 2013 | 2012 | |
| Net sales | $15,057 | $17,559 |
| Cost of sales | 8,624 | 10,781 |
| Gross profit | 6,433 | 6,778 |
| Operating expenses: | ||
| Engineering, design and product development | 1,012 | 1,213 |
| Selling and marketing | 1,786 | 1,601 |
| General and administrative | 2,034 | 2,000 |
| Legal fees associated with lawsuit | 199 | -- |
| Business consolidation and restructuring | -- | 54 |
| 5,031 | 4,868 | |
| Operating income | 1,402 | 1,910 |
| Interest and other income (expense): | ||
| Interest, net | (1) | 2 |
| Other, net | 37 | (24) |
| 36 | (22) | |
| Income before income taxes | 1,438 | 1,888 |
| Income tax provision | 278 | 680 |
| Net income | $1,160 | $1,208 |
| Net income per common share: | ||
| Basic | $0.13 | $0.13 |
| Diluted | $0.13 | $0.13 |
| Shares used in per share calculation: | ||
| Basic | 8,717 | 9,427 |
| Diluted | 8,809 | 9,532 |
|
SUPPLEMENTAL INFORMATION – SALES BY MARKET: |
||
|
Three months ended March 31, |
||
| 2013 | 2012 | |
| Food safety, banking and point of sale | $1,984 | $2,336 |
| Casino and gaming | 6,740 | 9,411 |
| Lottery | 1,365 | 1,030 |
| Printrex | 1,325 | 1,239 |
| TransAct services group | 3,643 | 3,543 |
| Total net sales | $15,057 | $17,559 |
| TRANSACT TECHNOLOGIES INCORPORATED | ||
| CONDENSED CONSOLIDATED BALANCE SHEETS | ||
| (Unaudited) | ||
| March 31, | December 31, | |
| (In thousands) | 2013 | 2012 |
| Assets: | ||
| Current assets: | ||
| Cash and cash equivalents | $8,449 | $7,537 |
| Accounts receivable, net | 10,784 | 15,927 |
| Inventories | 11,220 | 10,321 |
| Deferred tax assets | 1,443 | 1,443 |
| Other current assets | 771 | 471 |
| Total current assets | 32,667 | 35,699 |
| Fixed assets, net | 3,205 | 3,302 |
| Goodwill | 2,621 | 2,621 |
| Deferred tax assets | 1,187 | 1,172 |
| Intangible assets, net | 2,242 | 2,328 |
| Other assets | 94 | 106 |
| 9,349 | 9,529 | |
| Total assets | $42,016 | $45,228 |
| Liabilities and Shareholders' Equity: | ||
| Current liabilities: | ||
| Accounts payable | $4,023 | $6,422 |
| Accrued liabilities | 1,955 | 2,927 |
| Income taxes payable | 315 | 629 |
| Accrued contingent consideration | 136 | 136 |
| Deferred revenue | 315 | 93 |
| Total current liabilities | 6,744 | 10,207 |
| Deferred revenue, net of current portion | 160 | 168 |
| Deferred rent, net of current portion | 294 | 308 |
| Accrued acquisition consideration, net of current portion | 824 | 824 |
| Other liabilities | 376 | 352 |
| 1,654 | 1,652 | |
| Total liabilities | 8,398 | 11,859 |
| Shareholders' equity: | ||
| Common stock | 109 | 109 |
| Additional paid-in capital | 26,268 | 25,940 |
| Retained earnings | 25,349 | 24,708 |
| Accumulated other comprehensive loss, net of tax | (83) | (55) |
| Treasury stock, at cost | (18,025) | (17,333) |
| Total shareholders' equity | 33,618 | 33,369 |
| Total liabilities and shareholders' equity | $42,016 | $45,228 |
| TRANSACT TECHNOLOGIES INCORPORATED | |||
| RECONCILIATION OF GAAP EARNINGS FINANCIAL MEASURES TO CORRESPONDING NON-GAAP FINANCIAL MEASURES | |||
| (Unaudited, thousands of dollars, except percentages and per share amounts) | |||
|
Three months ended March 31, 2013 |
|||
|
|
Reported |
Adjustments(1) |
Adjusted Non-GAAP |
| Operating expenses | $5,031 | $(199) | $4,832 |
| % of net sales | 33.4% | 32.1% | |
| Operating income | 1,402 | 199 | 1,601 |
| % of net sales | 9.3% | 10.6% | |
| Income before income taxes | 1,438 | 199 | 1,637 |
| Income tax provision | 278 | 69 | 347 |
| Net income | 1,160 | 130 | 1,290 |
| Diluted net income per share | $0.13 | $0.02 | $0.15 |
| (1) Adjustment includes $199 of legal and other expenses related to the lawsuit with Avery Dennison Corporation, tax effected using an effective tax rate of 34.6%. | |||
|
Three months ended March 31, 2012 |
|||
|
|
Reported |
Adjustments (2) |
Adjusted Non-GAAP |
| Operating expenses | $4,868 | $(54) | $4,814 |
| % of net sales | 27.7% | 27.4% | |
| Operating income | 1,910 | 54 | 1,964 |
| % of net sales | 10.9% | 11.2% | |
| Income before income taxes | 1,888 | 54 | 1,942 |
| Income tax provision | 680 | 19 | 699 |
| Net income | 1,208 | 35 | 1,243 |
| Diluted net income per share | $0.13 | $0.00 | $0.13 |
|
(2) Adjustment includes a restructuring charge of $54 for employee termination benefits and moving expenses associated with the closing of the Printrex manufacturing facility in San Jose, CA during 2012 tax effected using an effective tax rate of 36.0%. |
|||